Sapatnekar, A. (2025). Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India. Journal of the Diabetic Association of India, 1(1). Retrieved from https://journals.onemd.in/index.php/jdai/article/view/59